17. Oral Complications in Hematopoietic Stem Cell Transplantation Survivorship

  1. Bipin N Savani MD
  1. Sharon Elad1,
  2. Corey Cutler2 and
  3. Nathaniel Treister3

Published Online: 6 SEP 2013

DOI: 10.1002/9781118473306.ch17

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

How to Cite

Elad, S., Cutler, C. and Treister, N. (2013) Oral Complications in Hematopoietic Stem Cell Transplantation Survivorship, in Blood and Marrow Transplantation Long-Term Management: Prevention and Complications (ed B. N. Savani), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118473306.ch17

Editor Information

  1. Professor of Medicine,Director, Long Term Transplant Clinic, Hematology and Stem Cell Transplantation Section, Vanderbilt University Medical Center, Nashville, TN, USA

Author Information

  1. 1

    Division of Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA

  2. 2

    Harvard Medical School, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

  3. 3

    Harvard School of Dental Medicine, Division of Oral Medicine and Dentistry, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA

Publication History

  1. Published Online: 6 SEP 2013
  2. Published Print: 1 OCT 2013

ISBN Information

Print ISBN: 9781118473405

Online ISBN: 9781118473306

SEARCH

Keywords:

  • oral health;
  • chronic graft-versus-host disease

Summary

HSCT survivors are at risk for developing a wide range of oral complications that can contribute to both morbidity and mortality after transplantation. Early recognition of oral complications is essential to ensure the best possible outcomes, and screening efforts should be performed routinely to detect problems and secondary oral malignancies while in their early stages. Referral to oral medicine experts may be required to manage some of these complications, particularly severe chronic oral graft-versus-host disease.